- Uses meaningful and efficient endpoints
- Discards poor treatments quickly
- Can cope with multiple treatments
- Minimizes burden on frontline staff
But foremost is adaptive.
Making sure that effective treatments reach patients quickly is particularly important in a new disease. Adaptive designs have the capability to react to the changing knowledge and multi-arm platform trials are an especially efficient way to evaluate the many treatment candidates.
A brilliant example of this is the new RECOVERY trial. This national clinical trial aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19.
Co-Investigator for the RECOVERY trial and Programme Leader at the BSU, Prof Thomas Jaki, says: “The RECOVERY trial is a great example of using efficient methods to bring benefit to patients and I am proud to be an active part in it.”
Find out more – www.recoverytrial.net